Global Dry Powder Inhaler Devices Market Insights, Forecast to 2025

Description

A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder.
Globally, increasing number of people with respiratory diseases and diabetes mellitus are expected to remain the growth drivers for dry powder inhaler devices during the period of study.
The global Dry Powder Inhaler Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dry Powder Inhaler Devices market based on company, product type, end user and key regions.

This report studies the global market size of Dry Powder Inhaler Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dry Powder Inhaler Devices in these regions.
This research report categorizes the global Dry Powder Inhaler Devices market by top players/brands, region, type and end user. This report also studies the global Dry Powder Inhaler Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer HealthCare
GlaxoSmithKline
Sandoz International
Teva Pharmaceutical Industries
Novartis
AKELA Pharma
Pharmaxis
Hovione FarmaCiencia
Nanotherapeutics
OPKO Health

Market size by Product
Capsule Based
Blister Based
Reservoir/Cartridge Based
Market size by End User
Hospitals and Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Dry Powder Inhaler Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dry Powder Inhaler Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dry Powder Inhaler Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dry Powder Inhaler Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Dry Powder Inhaler Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dry Powder Inhaler Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Dry Powder Inhaler Devices Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dry Powder Inhaler Devices Market Size Growth Rate by Product
1.4.2 Capsule Based
1.4.3 Blister Based
1.4.4 Reservoir/Cartridge Based
1.5 Market by End User
1.5.1 Global Dry Powder Inhaler Devices Market Size Growth Rate by End User
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Dry Powder Inhaler Devices Market Size
2.1.1 Global Dry Powder Inhaler Devices Revenue 2014-2025
2.1.2 Global Dry Powder Inhaler Devices Sales 2014-2025
2.2 Dry Powder Inhaler Devices Growth Rate by Regions
2.2.1 Global Dry Powder Inhaler Devices Sales by Regions
2.2.2 Global Dry Powder Inhaler Devices Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Dry Powder Inhaler Devices Sales by Manufacturers
3.1.1 Dry Powder Inhaler Devices Sales by Manufacturers
3.1.2 Dry Powder Inhaler Devices Sales Market Share by Manufacturers
3.1.3 Global Dry Powder Inhaler Devices Market Concentration Ratio (CR5 and HHI)
3.2 Dry Powder Inhaler Devices Revenue by Manufacturers
3.2.1 Dry Powder Inhaler Devices Revenue by Manufacturers (2014-2019)
3.2.2 Dry Powder Inhaler Devices Revenue Share by Manufacturers (2014-2019)
3.3 Dry Powder Inhaler Devices Price by Manufacturers
3.4 Dry Powder Inhaler Devices Manufacturing Base Distribution, Product Types
3.4.1 Dry Powder Inhaler Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dry Powder Inhaler Devices Product Type
3.4.3 Date of International Manufacturers Enter into Dry Powder Inhaler Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Dry Powder Inhaler Devices Sales by Product
4.2 Global Dry Powder Inhaler Devices Revenue by Product
4.3 Dry Powder Inhaler Devices Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Dry Powder Inhaler Devices Breakdown Data by End User

6 North America
6.1 North America Dry Powder Inhaler Devices by Countries
6.1.1 North America Dry Powder Inhaler Devices Sales by Countries
6.1.2 North America Dry Powder Inhaler Devices Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dry Powder Inhaler Devices by Product
6.3 North America Dry Powder Inhaler Devices by End User

7 Europe
7.1 Europe Dry Powder Inhaler Devices by Countries
7.1.1 Europe Dry Powder Inhaler Devices Sales by Countries
7.1.2 Europe Dry Powder Inhaler Devices Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dry Powder Inhaler Devices by Product
7.3 Europe Dry Powder Inhaler Devices by End User

8 Asia Pacific
8.1 Asia Pacific Dry Powder Inhaler Devices by Countries
8.1.1 Asia Pacific Dry Powder Inhaler Devices Sales by Countries
8.1.2 Asia Pacific Dry Powder Inhaler Devices Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Dry Powder Inhaler Devices by Product
8.3 Asia Pacific Dry Powder Inhaler Devices by End User

9 Central & South America
9.1 Central & South America Dry Powder Inhaler Devices by Countries
9.1.1 Central & South America Dry Powder Inhaler Devices Sales by Countries
9.1.2 Central & South America Dry Powder Inhaler Devices Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Dry Powder Inhaler Devices by Product
9.3 Central & South America Dry Powder Inhaler Devices by End User

10 Middle East and Africa
10.1 Middle East and Africa Dry Powder Inhaler Devices by Countries
10.1.1 Middle East and Africa Dry Powder Inhaler Devices Sales by Countries
10.1.2 Middle East and Africa Dry Powder Inhaler Devices Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dry Powder Inhaler Devices by Product
10.3 Middle East and Africa Dry Powder Inhaler Devices by End User

11 Company Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Company Business Overview
11.1.3 Bayer HealthCare Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer HealthCare Dry Powder Inhaler Devices Products Offered
11.1.5 Bayer HealthCare Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Dry Powder Inhaler Devices Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Sandoz International
11.3.1 Sandoz International Company Details
11.3.2 Company Business Overview
11.3.3 Sandoz International Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sandoz International Dry Powder Inhaler Devices Products Offered
11.3.5 Sandoz International Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Company Business Overview
11.4.3 Teva Pharmaceutical Industries Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Teva Pharmaceutical Industries Dry Powder Inhaler Devices Products Offered
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Company Business Overview
11.5.3 Novartis Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Novartis Dry Powder Inhaler Devices Products Offered
11.5.5 Novartis Recent Development
11.6 AKELA Pharma
11.6.1 AKELA Pharma Company Details
11.6.2 Company Business Overview
11.6.3 AKELA Pharma Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AKELA Pharma Dry Powder Inhaler Devices Products Offered
11.6.5 AKELA Pharma Recent Development
11.7 Pharmaxis
11.7.1 Pharmaxis Company Details
11.7.2 Company Business Overview
11.7.3 Pharmaxis Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pharmaxis Dry Powder Inhaler Devices Products Offered
11.7.5 Pharmaxis Recent Development
11.8 Hovione FarmaCiencia
11.8.1 Hovione FarmaCiencia Company Details
11.8.2 Company Business Overview
11.8.3 Hovione FarmaCiencia Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Hovione FarmaCiencia Dry Powder Inhaler Devices Products Offered
11.8.5 Hovione FarmaCiencia Recent Development
11.9 Nanotherapeutics
11.9.1 Nanotherapeutics Company Details
11.9.2 Company Business Overview
11.9.3 Nanotherapeutics Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Nanotherapeutics Dry Powder Inhaler Devices Products Offered
11.9.5 Nanotherapeutics Recent Development
11.10 OPKO Health
11.10.1 OPKO Health Company Details
11.10.2 Company Business Overview
11.10.3 OPKO Health Dry Powder Inhaler Devices Sales, Revenue and Gross Margin (2014-2019)
11.10.4 OPKO Health Dry Powder Inhaler Devices Products Offered
11.10.5 OPKO Health Recent Development

12 Future Forecast
12.1 Dry Powder Inhaler Devices Market Forecast by Regions
12.1.1 Global Dry Powder Inhaler Devices Sales Forecast by Regions 2019-2025
12.1.2 Global Dry Powder Inhaler Devices Revenue Forecast by Regions 2019-2025
12.2 Dry Powder Inhaler Devices Market Forecast by Product
12.2.1 Global Dry Powder Inhaler Devices Sales Forecast by Product 2019-2025
12.2.2 Global Dry Powder Inhaler Devices Revenue Forecast by Product 2019-2025
12.3 Dry Powder Inhaler Devices Market Forecast by End User
12.4 North America Dry Powder Inhaler Devices Forecast
12.5 Europe Dry Powder Inhaler Devices Forecast
12.6 Asia Pacific Dry Powder Inhaler Devices Forecast
12.7 Central & South America Dry Powder Inhaler Devices Forecast
12.8 Middle East and Africa Dry Powder Inhaler Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dry Powder Inhaler Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample